We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CMI:NYSECummins Inc. Analysis

Data as of 2026-05-27 - not real-time

$664.02

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Cummins Inc. (CMI) is trading above its short‑term and mid‑term moving averages, reinforcing a bullish price trend despite a recent dip toward a key support zone. The relative strength index sits near the neutral midpoint, suggesting limited overbought pressure, while the MACD histogram remains in negative territory, flagging short‑term momentum weakness. Volume has been stable, and the stock benefits from an “extreme greed” market sentiment, which supports continued buying interest.
Fundamentally, the company posted modest revenue growth and beat top‑line expectations, though earnings fell short of consensus. Analysts have raised the 2026 revenue outlook, and the consensus price targets remain materially above the current level, implying upside potential. Dividend sustainability appears solid with a moderate payout ratio and strong cash flow, while valuation metrics such as price‑to‑earnings and price‑to‑book are elevated relative to peers, indicating the stock may be priced on growth expectations.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price remains above key moving averages
  • MACD bearish divergence warns of near‑term pullback
  • support level holds and dividend payout adds cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • raised revenue outlook and positive earnings momentum
  • analyst price targets suggest upside
  • sustainable dividend and strong cash generation

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • diversified industrial portfolio and exposure to clean‑energy transition
  • elevated valuation relative to earnings and book value
  • steady dividend and robust balance sheet support resilience

Key Metrics & Analysis

Financial Health

Revenue Growth2.70%
Profit Margin7.89%
P/E Ratio34.5
ROE21.99%
ROA7.27%
Debt/Equity61.62
P/B Ratio7.4
Op. Cash Flow$3.9B
Free Cash Flow$1.7B
Industry P/E30.2

Technical Analysis

TrendBullish
RSI51.4
Support$628.09
Resistance$718.08
MA 20$676.26
MA 50$621.69
MA 200$521.16
MACDBearish
VolumeStable
Fear & Greed Index91.95

Valuation

Fair Value$142.54
Target Price$725.12
Upside/Downside9.20%
GradeOvervalued
TypeBlend
Dividend Yield1.20%

Risk Assessment

Beta1.61
Volatility42.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.